Andrew D Tieniber (Andrew Tieniber)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Epidermal Growth Factor Receptor

Advanced Non Small Cell Lung Cancer

Top Venues

Cancer immunology research

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Ferdinando Rossi, Mengyuan Liu, Andrew D Tieniber, Mark S Etherington, Andrew N Hanna, Gerardo A Vitiello, Nesteene J Param, Kevin J Do, Laura Wang, Cristina R Antonescu, Shan Zeng, Jennifer Q Zhang, Ronald P DeMatteo
Myosin light chain kinase inhibition potentiates the anti-tumor effects of avapritinib in PDGFRA D842V-mutant gastrointestinal stromal tumor. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Mark S Etherington, Andrew N Hanna, Benjamin D Medina, Mengyuan Liu, Andrew D Tieniber, Hyunjee V Kwak, Katherine J Tardy, Lillian Levin, Kevin J Do, Ferdinando Rossi, Shan Zeng, Ronald P DeMatteo
Tyrosine kinase inhibition activates intratumoral ϒδ T cells in gastrointestinal stromal tumor. Cancer immunology research (2023)
Andrew D Tieniber, Andrew N Hanna, Benjamin D Medina, Gerardo A Vitiello, Mark S Etherington, Mengyuan Liu, Kevin J Do, Ferdinando Rossi, Ronald P DeMatteo
Tyrosine Kinase Inhibition Alters Intratumoral CD8+ T-cell Subtype Composition and Activity. Cancer immunology research 10 (10) (2022)